Viking Therapeutics (VKTX) has been on a wild ride this year, with shares sliding over the past month even after a massive run in the past 3 years. So what is the market rethinking here? See our ...

Viking Therapeutics Inc. (NASDAQ:VKTX) is one of the stocks that will double in 2026. Earlier on November 12, Canaccord ...

Eli Lilly (NYSE:LLY) is rapidly establishing itself as the leader in GLP-1 treatments for weight loss. Its Zepbound injection ...

For those willing to take a chance, let's consider two biotech stocks that could eventually become solid, well-established drugmakers: CRISPR Therapeutics(NASDAQ: CRSP) and Viking Therapeutics(NASDAQ: ...

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $36.15, marking a -2.51% move from the previous day. This move lagged the S&P 500's daily loss of 0.16%. Meanwhile, the Dow ...

Upstart biotech company Viking Therapeutics (NASDAQ: VKTX) is a potential takeover candidate in 2026. That's not a reason to ...

According to analyst H.C. Wainwright, the positive study result from Lilly materially de-risks Viking's (VKTX) oral VK2735 ...

We recently published 7 Best ASX Stocks to Buy Right Now. Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the best ASX stocks. Telix Pharmaceuticals Limited (NASDAQ:TLX) is a biotechnology ...

Altimmune (ALT) stock is in focus as the company announces data from a mid-stage trial for its MASH therapy pemvidutide ...

Sanofi sees continued growth and strong financials despite a pipeline setback. Click for this updated look at SNY stock ...

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, ...